Swiss National Bank - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 74 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.14 and the average weighting 0.1%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,320,899
-14.2%
298,700
+6.9%
0.00%0.0%
Q2 2023$2,703,624
-5.4%
279,300
+7.1%
0.00%0.0%
Q1 2023$2,857,272
+127.1%
260,700
-10.5%
0.00%
+100.0%
Q4 2022$1,257,984
-41.4%
291,200
+1.9%
0.00%
-50.0%
Q3 2022$2,148,000
-18.0%
285,700
+9.6%
0.00%0.0%
Q2 2022$2,619,000
-18.8%
260,6000.0%0.00%0.0%
Q1 2022$3,226,000
-41.3%
260,600
+8.5%
0.00%
-33.3%
Q4 2021$5,493,000
+9.6%
240,200
+6.0%
0.00%0.0%
Q3 2021$5,012,000
+71.1%
226,500
+0.4%
0.00%
+50.0%
Q2 2021$2,929,000
-8.4%
225,500
-8.3%
0.00%0.0%
Q1 2021$3,196,000
-5.1%
245,900
+0.8%
0.00%0.0%
Q4 2020$3,368,000
-5.8%
244,0000.0%0.00%
-33.3%
Q3 2020$3,577,000
+22.8%
244,000
+35.1%
0.00%
+50.0%
Q2 2020$2,912,000
+29.8%
180,600
+14.7%
0.00%0.0%
Q1 2020$2,244,000
-27.2%
157,400
+3.2%
0.00%
-33.3%
Q4 2019$3,084,000
+373.7%
152,500
+25.0%
0.00%
+200.0%
Q3 2019$651,000
-11.8%
122,000
+9.1%
0.00%0.0%
Q2 2019$738,000
+15.9%
111,800
+14.0%
0.00%0.0%
Q1 2019$637,000
-4.5%
98,1000.0%0.00%0.0%
Q4 2018$667,000
+9.7%
98,100
+6.2%
0.00%0.0%
Q3 2018$608,000
+14.7%
92,4000.0%0.00%0.0%
Q2 2018$530,000
+9.1%
92,4000.0%0.00%0.0%
Q1 2018$486,000
+15.4%
92,4000.0%0.00%
Q4 2017$421,00092,4000.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Berry Street Capital Management LLP 1,987,500$24,605,0002.79%
NEA Management Company, LLC 3,969,834$49,146,0001.42%
IRONWOOD INVESTMENT MANAGEMENT LLC 133,117$1,648,0000.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 435,000$3,955,0000.89%
ACT CAPITAL MANAGEMENT, LLC 67,500$836,0000.88%
Artal Group S.A. 1,000,000$12,380,0000.52%
CTC Capital Management, LLC 12,800$158,0000.42%
KESTRA PRIVATE WEALTH SERVICES, LLC 581,910$7,204,0000.36%
Affinity Asset Advisors, LLC 175,000$2,167,0000.35%
Bellevue Group AG 2,405,825$29,784,0000.35%
View complete list of AURINIA PHARMACEUTICALS INC shareholders